Débora Amado

Débora Amado

Auto-generated profile, based on publicly available information

Débora Amado

Universidade Federal de Sao Paulo, Brasil

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2001 in Epilepsy Research
Verified
Journal Article
Closed access
MBMaria I. Bellissimo
Maria I. Bellissimo
DADébora Amado
Débora Amado
DADulcinéia S.P. Abdalla
Dulcinéia S.P. Abdalla
EFEdimar C. Ferreira
Edimar C. Ferreira
ECEsper A. Cavalheiro
Esper A. Cavalheiro
MNMaria da Graça Naffah-Mazzacoratti
Maria da Graça Naffah-Mazzacoratti

1 September 1998 in Epilepsy Research
Verified
Journal Article
Closed access
DAD Amado
D Amado
ECE.A Cavalheiro
E.A Cavalheiro

28 July 2008 in Epilepsia
Verified
Journal Article
Open access
PDF file
GAGustavo Adolfo Argañaraz
Gustavo Adolfo Argañaraz
AKAna Carla Konno
Ana Carla Konno
SPSandra Regina Perosa
Sandra Regina Perosa
JSJoselita Ferreira Carvalho Santiago
Joselita Ferreira Carvalho Santiago
MBMirian A Boim
Mirian A Boim
MMMaria Da Graça Naffah Mazzacoratti
Maria Da Graça Naffah Mazzacoratti
Summary: Purpose: As reported by several authors, angiotensin II (AngII) is a proinflammatory molecule that stimulates the release of inflammatory cytokines and activates nuclear factor κB (NFκB), being also associated with the increase of cellular oxidative stress. Its production depends on the activity of the angiotensin converting enzyme (ACE) that hydrolyzes the inactive precursor angiotensin I (AngI) into AngII. It has been suggested that AngII underlies the physiopathological mechanisms of several brain disorders such as stroke, bipolar disorder, schizophrenia, and disease. The aim of the present work was to localize and quantify AngII AT1 and AT2 receptors in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis (MTS) submitted to corticoamygdalohippocampectomy for seizure control. Method: Immunohistochemistry, Western blot, and real‐time PCR techniques were employed to analyze the expression of these receptors. Results: The results showed an upregulation of AngII AT1 receptor as well as its messenger ribonucleic acid (mRNA) expression in the cortex and hippocampus of patients with MTS. In addition, an increased immunoexpression of AngII AT2 receptors was found only in the hippocampus of these patients with no changes in its mRNA levels. Discussion: These data show, for the first time, changes in components of renin‐angiotensin system (RAS) that could be implicated in the physiopathology of MTS.


1 May 2005 in Brain Research
Verified
Journal Article
Closed access
ELEliângela de Lima
Eliângela de Lima
JSJosé Maria Soares
José Maria Soares
YGYaima del Carmen Sanabria Garrido
Yaima del Carmen Sanabria Garrido
SVSandra Gomes Valente
Sandra Gomes Valente
MPMargareth Rose Priel
Margareth Rose Priel
DADébora Amado
Débora Amado

1 April 2004 in Brain Research
Verified
Journal Article
Closed access
GAGustavo Adolfo Argañaraz
Gustavo Adolfo Argañaraz
JSJosé Antônio Silva
José Antônio Silva
SPSandra Regina Perosa
Sandra Regina Perosa
LPLuciana Gilbert Pessoa
Luciana Gilbert Pessoa
FCFátima Ferreira Carvalho
Fátima Ferreira Carvalho
MNMaria da Graça Naffah-Mazzacoratti
Maria da Graça Naffah-Mazzacoratti